University of California San Francisco
Give to UCSF
Faculty members Chase Anderson, MD, and Brittany Bryant, LCSW, help us understand what microaggressions are, what they look like, and what they mean for your mental health – and practical skills to deal with them, whether they’re directed at you or not.
From left to right: W. Thomas Boyce, MD; Kathleen Giacomini, PhD; Geeta Narlikar, PhD; and Neil Powe, MD, MPH, MBA.Four scientists and clinicians at UC San Francisco have been honored this year with
As the human body ages, cellular changes can drive a host of age-related diseases and conditions. The appearance of aging cells, also called senescent cells, in age-related diseases has spurred the
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
When a mouthful of water goes down the wrong pipe – heading toward a healthy person’s lungs instead of their gut – they start coughing uncontrollably. That’s because their upper airway senses the
Mild brain inflammation destroys arm-like projections of neurons rather than the neurons themselves, but can still cause significant brain damage.
A study reveals the life-altering impact of COVID-19 on individuals who developed severe illness, the majority of whom had to be placed on mechanical ventilators. Two-thirds still had physical, psychiatric, and cognitive problems for up to a year later.
Increased obesity worldwide has become a leading cause of cardiovascular diseases. A new study by UC San Francisco and the Broad Institute of MIT and Harvard researchers found the quantity of fat
UCSF scientists have been awarded more than $30 million to develop “tissue GPS,” a new system using engineered T cells to guide therapies directly to their targets in the brain to treat neurological diseases like cancer, multiple sclerosis and Alzheimer’s.
A smartphone app could enable greater participation in clinical trials for people with frontotemporal dementia (FTD), a devastating neurological disorder that often manifests in mid-life.
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.
